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We tested 41 bats for antibodies against Nipah and Hen-
dra viruses to determine whether henipaviruses circulate 
in pteropid fruit bats (Pteropus giganteus) in northern In-
dia. Twenty bats were seropositive for Nipah virus, which 
suggests circulation in this species, thereby extending the 
known distribution of henipaviruses in Asia westward by 
>1,000 km.
N
ipah virus (NiV) and Hendra virus (HeV) are zoonot-
ic paramyxoviruses (genus Henipavirus) that have 
caused human deaths in Australia, Malaysia, Singapore, 
India, and Bangladesh (1–4). Known reservoirs for heni-
paviruses are Pteropus spp. fruit bats, which are distributed 
across the Indo-Paciﬁ  c region from Madagascar eastward 
to the South Paciﬁ  c islands (5). Evidence of henipavirus 
infection has been reported in Pteropus bats from Malay-
sia, Bangladesh, Australia, Thailand, Cambodia, Indonesia, 
and Madagascar, which supports the theory that these bats 
have co-evolved with henipaviruses (6–8).
The ﬁ  rst known outbreak of NiV encephalitis in In-
dia occurred in 2001 in Siliguri, West Bengal (1). The fruit 
bat (P. giganteus) is present across the Indian subcontinent 
and, although it is suspected as the reservoir host for NiV 
in Bangladesh, its status as a reservoir for henipaviruses 
in India is unknown. Seven outbreaks of NiV encephalitis 
were recognized in Bangladesh from 2000 through 2008, 
and antibodies to NiV have been found in P. giganteus in 
several colonies there, including colonies adjacent to hu-
man case-patients (3,5,9). In the current study, we exam-
ined a population of P. giganteus bats in India, >1,000 km 
west of Siliguri, for antibodies to henipaviruses.
The Study
We captured 41 P. giganteus bats from a colony in 
Haryana State in northern India from June 24 through June 
30, 2003, by using mist nets. Blood was collected from 
the brachial or cephalic artery or from the vein by using 
a heparinized 3.0-mL syringe and a 22-gauge or 27-gauge 
needle and stored for 24 hours at 4°C to allow for plasma 
separation; the separated plasma was then stored at –20°C 
until use. Sex, age, body condition score, pregnancy sta-
tus, lactation status, weight, and forearm length were re-
corded. Age was estimated by the presence of secondary 
sexual characteristics and dental wear. Body condition was 
assessed by digital palpation of the pectoral muscles and 
individuals were assigned a body condition score (BCS) 
of “poor,” “fair,” or “good.” Unweaned juveniles were 
not assigned a BCS because of their physical immaturity. 
Pregnancy was determined by digital palpation, and a bat 
was considered “lactating” if milk could be expressed from 
either teat. All bats were released after sampling.
All 41 plasma samples were screened for antibodies 
to NiV and HeV by using virus-speciﬁ  c indirect ELISAs. 
Thirty-nine samples (2 samples had insufﬁ  cient amounts of 
plasma remaining) were analyzed by using NiV and HeV 
serum neutralization tests (SNTs) under Biosafety Level 4 
conditions (10). For the ELISA, coating antigen was de-
rived from puriﬁ  ed HeV- and NiV-infected Vero cells, and 
positive control serum specimens were obtained from ex-
perimentally infected horses (HeV) and pigs (NiV). Pro-
tein A/G conjugate was used to detect bound bat serum. A 
ﬁ  nal serum dilution of 1:50 was used for the bat samples. 
A sample was considered reactive if the ratio of its aver-
age optical density at 450 nm (OD450) of infected Vero cell 
antigen-coated wells (each sample was tested in duplicate) 
to uninfected Vero cell antigen-coated wells was >2.0 and 
the average OD450 value for the sample in the infected Vero 
cell antigen-coated wells was >0.2. Positive control serum 
samples were conﬁ  rmed by both ELISA and SNT. SNT 
results were considered positive if virus neutralization oc-
curred at >1:5 dilution (11). If neutralizing antibodies were 
present for both HeV and NiV, the higher titer was consid-
ered the positive test only if the difference between them 
was >4-fold (11). Samples that had positive titers to both 
viruses that differed by <4-fold were considered positive 
for an unspeciﬁ  ed henipavirus.
The results of the serologic tests are presented in the 
Table, including comparisons of the results by gender, lac-
tation status (females), and BCS. Twenty-six (63%) of 41 
samples (95% conﬁ  dence interval [CI] 47%–78%) were 
reactive in the NiV ELISA, 5 of which were also reactive 
in the HeV ELISA. No plasma samples reacted only in the 
HeV ELISA. Twenty (51%) of 39 samples (95% CI 35%–
68%) had neutralizing antibodies to NiV, and 10 (26%) 
of 39 (95% CI 13%–42%) had neutralizing antibodies to 
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neutralizing titer of 5 to NiV and HeV. This sample reacted 
in the NiV ELISA, but not in the HeV ELISA, although 
because it had equivalent neutralizing titers to both viruses, 
it was considered positive for an unspeciﬁ  ed henipavirus. 
The ELISA showed 95% sensitivity and 75% speciﬁ  city 
compared with the SNT.
Each of 2 unweaned pups matched their mother’s se-
rostatus, with 1 pup positive by SNT (pup 80, mother >640). 
Samples of the other mother–pup pair were seronegative. 
There were no signiﬁ  cant differences in the NiV seropreva-
lence in male bats on SNT (8/12) compared to female bats 
(12/27) by using a Fisher exact test (FET; p = 0.300) or in 
lactating female bats (8/19) compared to nonlactating (5/8) 
female bats (FET; p = 0.420). We found signiﬁ  cant differ-
ences in seroprevalence between bats with a poor and fair 
BCS (FET; p = 0.005), with bats in poor condition having 
a lower antibody prevalence than those with fair BCS. No 
difference in seroprevalence was found between the poor 
and good BCS groups or the fair and good groups.
Conclusions
Our study provides evidence that NiV, or a closely re-
lated henipavirus, circulates in Indian fruit bats (P. gigan-
teus), thereby extending the range of the genus Henipavirus 
in Asia westward by >1,000 km. Our results are consistent 
with reports of NiV in P. giganteus bats in Bangladesh (3) 
and with Pteropus spp. being the primary reservoir of heni-
paviruses (5). Logistical limitations prevented us from at-
tempting virus isolation and testing for viral RNA.
Previous studies have demonstrated that ELISAs, al-
though less speciﬁ  c than SNTs, are useful screening tests 
for henipaviruses (11). Our results support this assertion, 
with the ELISA showing a high sensitivity. In our study, 
neutralizing antibodies to HeV and NiV were detected in 
11 bats, 10 of which exhibited a >4-fold titer to NiV anti-
bodies. Concurrent HeV and NiV titers are considered due 
to cross-neutralization rather than exposure to both viruses 
(6,11,12). Serologic studies provide information about the 
proportion of a population exposed to NiV, but not about 
the prevalence of bats that may be shedding virus or the 
virus itself. Further work in this area is required to fully 
characterize the henipavirus(es) involved and to conﬁ  rm 
the status of P. giganteus as a reservoir.
Researchers have suggested that pregnancy plays a 
key role in henipavirus transmission among Australian 
Pteropus spp. and from bats to other species (13,14). In 
our study, we found no signiﬁ  cant difference in seropreva-
lence between sexes, or between lactating and nonlactating 
females. Of the 2 lactating females carrying pups, 1 had 
a high titer of >640 and its pup had a titer of 80 against 
NiV, which suggests the passive transfer of antibodies; 
the other dam–pup pair was seronegative. Seroprevalence 
appeared to be signiﬁ  cantly greater in bats with fair BCS 
when compared with those with poor BCS; however, no 
signiﬁ  cant differences were found between good and poor 
or good and fair BCS groups. The ﬁ  ndings that bats with 
fair BCS had a higher seroprevalence than poor BCS bats, 
but that there was no difference between good BCS bats 
and the other 2 groups, may be explained by the subjective 
classiﬁ  cation of a bat’s body condition. Those bats deemed 
to have fair body condition may have been more similar to 
those with robust bodies (good BCS) than those with thin, 
emaciated bodies (poor BCS). In fact, if one combines the 
good and fair categories, and compares the seroprevalence 
(18/28) with that of the poor group, the difference is still 
signiﬁ  cant (p = 0.007); by contrast, combining the fair and 
poor categories (17/32) and comparing that seroprevalence 
to the good category results in no signiﬁ  cant difference (p 
= 0.660). Having a lower seroprevalence in bats with the 
DISPATCHES
1310  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 8, August 2008
Table. ELISA and SNT results and univariate associations between serostatus and other variables for wild-caught Pteropus giganteus
bats in India* 
ELISA SNT
Characteristic
No. NiV reactive/ 
no. tested
No. HeV reactive/ 
no. tested
No. NiV positive/total (%)
[median titer; range]
NiV SNT comparisons,  
p value†
Total 26/41 5/41 20/39‡ (51) [80; 5–640]
Male 10/12 3/12 8/12 (67) [60; 20–640]
Female 16/29 2/29 12/27‡ (44) [80; 5–640]
0.300
  Lactating 12/20 2/20 8/19‡ (42) [80;20–640]
  Nonlactating 4/9 0/9 4/8‡ (50) [80;5–80]
1.00
Body condition score§ 
  Poor 5/9 0/9 1/9 (11) [640; NA]
  Fair 16/24 5/24 16/23 (70) [80; 5–640]
  Good 3/6 0/6 2/5 (40) [60; 40–80]
P v F: 0.005;
F v G: 0.315;  
P v G: 0.505
*SNT, serum neutralization test; NiV, Nipah virus; HeV, Hendra virus; NA, not applicable; P, poor; F, fair; G, good. 
†Fisher exact test p value significant at <0.05. 
‡Two samples had insufficient plasma for SNT (both were ELISA negative); sample 1 was from a nonlactating adult female with a good body condition 
score (BCS) and the other was from a lactating adult with a fair BCS. A third sample, a nonlactating adult female with a good BCS had equivocal NiV/HeV 
SNT titers (5), which was attributed to an unspecified henipavirus and considered negative for NiV and HeV. 
§Two pre-weaned pups (1 male, NiV SNT negative; 1 female, NiV SNT positive titer 80) were excluded from the BCS dataset because of their physical 
immaturity.  Henipavirus Infection in Fruit Bats
poorest BCS may be explained as an artifact of the nonran-
dom sampling (we sampled those bats that were ﬁ  rst to be 
captured), by the limited sample, or it could suggest that 
NiV infection causes death in P. giganteus bats that are in 
poor physical condition. The latter explanation is less plau-
sible because experimental infections of Pteropus spp. with 
henipaviruses produce only subclinical infection with no 
illness or death (15).
In northern India, as in Bangladesh, P. giganteus 
bats live in close association with the human population. 
Indeed, the colony examined in this study lives in a busy 
town above a major tourist attraction. Previous studies of 
NiV encephalitis outbreaks in Bangladesh have identiﬁ  ed 
fresh date palm juice or fruit as plausible foodborne routes 
of transmission between bats and humans (3,16). The mul-
tiple outbreaks of NiV in Bangladesh, and the 2001 out-
break in West Bengal, show a continued risk for spillover 
infection between bats and humans in this region. Our 
ﬁ  ndings suggest that the risk for NiV spillover to humans 
should be considered over a much wider area than previ-
ously regarded.
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